Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Xilio Development, Inc.”

7 pharma patents match "Xilio Development, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "Xilio Development, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “Xilio Development, Inc.” · 30,257 patents in full index Clear search

  1. US 12384845

    Activatable masked anti-CTLA4 binding proteins

    Xilio Development, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted

  2. US 12280120

    Tumor-specific cleavable linkers

    Xilio Development, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted

  3. US 11866476

    Masked IL-2-Fc fusion polypeptides

    Xilio Development, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted

  4. US 11827686

    Masked cytokine polypeptides

    Xilio Development, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  5. US 11827685

    Masked cytokine polypeptides

    Xilio Development, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  6. US 11718655

    Masked interleukin-12 polypeptides

    Xilio Development, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted

  7. US 11053294

    Masked cytokine polypeptides

    Xilio Development, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.